Boston Partners’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$413M Sell
2,093,896
-21,000
-1% -$4.05M 0.43% 79
2025
Q4
$389M Sell
2,114,896
-508,829
-19% -$89.2M 0.4% 84
2025
Q3
$405M Buy
2,623,725
+128,763
+5% +$19.5M 0.42% 79
2025
Q2
$350M Sell
2,494,962
-23,361
-0.9% -$3.27M 0.39% 82
2025
Q1
$369M Buy
2,518,323
+664,583
+36% +$96.2M 0.45% 73
2024
Q4
$243M Buy
1,853,740
+1,835,360
+9,986% +$257M 0.3% 131
2024
Q3
$2.86M Buy
18,380
+16,407
+832% +$2.65M ﹤0.01% 478
2024
Q2
$309K Sell
1,973
-272
-12% -$40.9K ﹤0.01% 687
2024
Q1
$309K Buy
+2,245
New +$297K ﹤0.01% 733
2023
Q4
Sell
-1,554
Closed -$210K 712
2023
Q3
$210K Buy
1,554
+29
+2% +$3.96K ﹤0.01% 701
2023
Q2
$218K Sell
1,525
-293
-16% -$43.1K ﹤0.01% 686
2023
Q1
$252K Buy
+1,818
New +$245K ﹤0.01% 660
2014
Q1
Sell
-331,935
Closed -$19.7M 719
2013
Q4
$19.7M Sell
331,935
-2,294,117
-87% -$125M 0.04% 283
2013
Q3
$136M Buy
2,626,052
+2,532,101
+2,695% +$127M 0.33% 97
2013
Q2
$4.44M Buy
+93,951
New +$4.78M 0.01% 497

Other funds holding AZN